Guidance setting out the circumstances in which it may be appropriate to offer prophylactic antivirals to patients with a serious underlying medical condition or who are pregnant during the H1N1 swine influenza pandemic has been published by the Department of Health.
The document points out that routine prophylaxis is not recommended for most contacts of a case of H1N1 infection but that clinical judgement can be used for individuals who are at particularly high risk of flu complications.
Citation: The Pharmaceutical Journal URI: 10983015
Recommended from Pharmaceutical Press
Pharmaceutical Press is the publishing division of the Royal Pharmaceutical Society, and is a leading provider of authoritative pharmaceutical information used throughout the world.Visit rpharms.com